Advertisement

Canadian Journal of Public Health

, Volume 93, Issue 1, pp 21–25 | Cite as

The Effects of Aerial Spraying with Bacillus thuringiensis Kurstaki on Children with Asthma

  • Marty Pearce
  • Brian Habbick
  • Janice Williams
  • Margaret Eastman
  • Maureen Newman
Article

Abstract

Objective

To determine if aerially spraying a biological pesticide was associated with an increase in the symptoms or change in the Peak Expiratory Flow Rate of children with asthma.

Methods

A pre/post matched pairs cohort design was used. Children living in the spray zone were matched with children outside of the spray zone. Peak Expiratory Flow Rates, asthma symptoms and non-asthma symptoms were recorded in diaries.

Results

There were no differences in asthma symptom scores between subjects and controls, neither before nor after the spray; nor were there significant changes in Peak Expiratory Flow Rates for subjects after the spray period.

Conclusions

No evidence of adverse effects from the use of the biological pesticide was found. We believe that this is the first paper to address the issue of whether or not aerial spraying with Btk has a harmful effect on children with asthma.

Résumé

Objectif

Nous avons cherché à déterminer si l’épandage aérien d’un pesticide biologique était associé à une hausse des symptômes ou à un changement du débit maximal expiratoire chez les enfants asthmatiques.

Méthode

Au moyen de cohortes avant-après en paires appariées, nous avons comparé des enfants vivant dans la zone d’épandage à des enfants vivant hors de la zone et consigné par écrit leurs débits maximaux expiratoires et leurs symptômes asthmatiques et non asthmatiques.

Résultats

Les cas et les témoins ont obtenu les mêmes scores en ce qui a trait aux symptômes de l’asthme avant et après l’épandage; nous n’avons pas non plus constaté de changements importants dans le débit maximal expiratoire des cas après l’épandage.

Conclusions

Nous n’avons relevé aucune preuve d’effets indésirables de l’emploi du pesticide biologique Btk. Selon nous, cette étude est la première sur d’éventuels effets néfastes, pour les enfants asthmatiques, de l’épandage aérien au Btk.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    van Netten C, Teschke K, Leung V, Chow Y, Bartlett K. The measurement of volatile constituents in Foray 48B, an insecticide prepared from Bacillus thuringiensis var. kurstaki. The Science of the Total Environment 2000;263:.155–60.CrossRefGoogle Scholar
  2. 2.
    Green M, Heumann M, Sokolow R, Foster L, Bryant R, Skeels M. Public health implications of the microbial pesticide Bacillus thuringiensis: An epidemiological study. Oregon, 1985–86. Am J Public Health 1990;80(7).848–52.CrossRefGoogle Scholar
  3. 3.
    Noble MA, Riben PD, Cook GJ. Microbiological and epidemiological surveillance programme to monitor the health effects of Foray 48B Btk spray. Report to the British Columbia Ministry of Forests. September 30, 1992.Google Scholar
  4. 4.
    Noble MA, Kandola P, Amos M, Riben P, Cook G, Shaw C. Cluster analysis of community retrieved isolates of Bacillus thuringiensis var kurstaki (BTK). 93rd General Meeting for the American Society of Microbiology. Las Vegas, Nevada. May 1994.Google Scholar
  5. 5.
    Anon. Report of health surveillance activities: Gypsy Moth control program. Health Promotion and Disease Prevention. Washington State Department of Health. March 1993.Google Scholar
  6. 6.
    Anon. Health risk assessment of the proposed 1997-98-control program for White-Spotted Tussock Moth in eastern suburbs of Auckland. Public Health Protection Services. Auckland Healthcare Services. Report to the New Zealand Ministry of Forestry. 1997.Google Scholar
  7. 7.
    Anon. Reregistration Eligibility Decision: Bacillus thuringiensis. United States Environmental Protection Agency. Prevention, Pesticides and Toxic Substances (7508W). EPA738-R-98-004. 1998.Google Scholar
  8. 8.
    Bernstein IL, Berstein JA, Miller M, Tierzieva S, Berstein DI, Lummus Z, et al. Immune response in farm workers after exposure to Bacillus thuringiensis pesticides. Environ Health Perspect 1999;107(7).575–82.CrossRefGoogle Scholar
  9. 9.
    Damgaard PH, Larsen HD, Bresciani J, Jorgensen K. Enterotoxin-producing strains of Bacillus thuringiensis isolated from food. Letters in Appl Micro 1996;23:.146–50.CrossRefGoogle Scholar
  10. 10.
    Drobniewski FA. The safety of Bacillus species as insect vector control agents. J Appl Bacteriology 1994;76:.101–9.CrossRefGoogle Scholar
  11. 11.
    McClintock JT, Schaffer CR, Sjoblad RD. A comparative review of the mammalian toxicity of Bacillus thuringiensis-based pesticides. Pestic Sci 1995;45:.95–105.CrossRefGoogle Scholar
  12. 12.
    Durkin PR, Fanfarillo PA, Campbell R, Meylan W, Gray DA, Diamond G. Human health risk assessment for the Gypsy Moth control and eradication program. Report submitted to the United States Department of Agriculture (Animal and Plant Health Inspection Service). USDA Purchase Order No. 43-3604-5-0116. 1995.Google Scholar
  13. 13.
    The Mammalian Safety of Bacillus thuringiensis Based Insecticides. J Invert Pathog 2001;77(1).13–21.CrossRefGoogle Scholar
  14. 14.
    Alberta Asthma Centre, 11402 University Avenue, Aberhart Centre, 3rd Floor, Edmonton, Alberta, Canada, T6E 6K2. Tel: 780-407-3175. https://doi.org/www.asthmacentre.org
  15. 15.
    Kennedy DT, Chang Z, Small R. Selection of peak flow meters in ambulatory asthma patients. Chest 1998;114:.587–92.CrossRefGoogle Scholar
  16. 16.
    Teschke K, Chow Y, Bartlett K, Ross A, van Netten C. Spatial and temporal distribution of airborne Bacillus thuringiensis var. kurstaki during an aerial spray program for gypsy moth eradication. Environ Health Perspect 2001;109(1).47–54.CrossRefGoogle Scholar
  17. 17.
    Valadares de Amorim G, Whittome B, Shore B, Levin D. Identification of Bacillus thuringiensis subsp. kurstaki Strain HD1-Like Bacteria from Environmental and Human Samples after Aerial Spraying of Victoria, British Columbia, Canada, with Foray 48B. Appl Environ Microbiol 2001;67(3).1035–43.CrossRefGoogle Scholar
  18. 18.
    Hospital for Sick Children. Handbook of Pediatrics, 8th edition, Shefler AG (Ed.). St Louis: Mosby Year Book Inc., 1992.Google Scholar
  19. 19.
    Jain P, Kavuru MS, Emerman CL, Ahmad M. Utility of peak expiratory flow monitoring. Chest 1998;114:.861–76.CrossRefGoogle Scholar
  20. 20.
    Ernst P, Fitzgerald JM, Speir S. Canadian Asthma Consensus Conference Summary of Recommendations. Can Respir J 1996;3(2).89–100.CrossRefGoogle Scholar

Copyright information

© The Canadian Public Health Association 2002

Authors and Affiliations

  • Marty Pearce
    • 1
    • 3
  • Brian Habbick
    • 2
  • Janice Williams
    • 1
  • Margaret Eastman
    • 1
  • Maureen Newman
    • 1
  1. 1.Capital Health RegionVictoriaCanada
  2. 2.University of SaskatchewanSaskatoonCanada
  3. 3.Capital Health RegionVictoriaCanada

Personalised recommendations